Powder: -20°C for 3 years | In solvent: -80°C for 1 year
L-(+)-Arabinose inhibits intestinal sucrase activity, thereby reducing sucrose utilization, and consequently decreasing lipogenesis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 42.00 | |
1 g | In stock | $ 50.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 30.00 |
Description | L-(+)-Arabinose inhibits intestinal sucrase activity, thereby reducing sucrose utilization, and consequently decreasing lipogenesis. |
In vitro | L-(+)-Arabinose is associated with ribose-5-phosphate isomerase deficiency, an inborn metabolic error[1]. It selectively inhibits intestinal sucrase in a noncompetitive manner, thereby suppressing the increase in plasma glucose following sucrose consumption[1]. |
In vivo | L-(+)-Arabinose feeding reduced the weights of epididymal adipose tissue in rats. Moreover, plasma insulin and triacylglycerol concentrations were significantly reduced by dietary L-(+)-Arabinose[1]. L-(+)-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice[2]. |
Molecular Weight | 150.13 |
Formula | C5H10O5 |
CAS No. | 5328-37-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (266.44 mM), Sonication is recommended.
H2O: 400 mg/mL (2664.36 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
L-(+)-Arabinose 5328-37-0 Metabolism Endogenous Metabolite inhibit Inhibitor L-Arabinose L (+) Arabinose L(+)Arabinose inhibitor